Zdrowie i gospodarka · 07/10/2020

FDA Announces Fee Rates for Tropical Disease Priority Review Vouchers for Fiscal Year 2021

The US Food and Drug Administration (FDA) has set the fee rates for using a tropical disease priority review voucher for the 2021 fiscal year, as mandated by the Federal Food, Drug, and Cosmetic Act (FD&C Act) and the Food and Drug Administration Amendments Act of 2007 (FDAAA).